Status:
COMPLETED
SWISS_EVIDENCE - Compartment Compressibility Monitoring Using CPM#1
Lead Sponsor:
Compremium AG
Conditions:
Compartment Syndromes
Eligibility:
All Genders
18-84 years
Phase:
NA
Brief Summary
Compartment syndrome is a very serious musculoskeletal disorder, which can lead to potentially devastating consequences, such as limb amputation and life-threatening conditions. It is a well described...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Male and female
- Age between 18 and 84
Exclusion
- Previous surgery to or fracture of the lower leg
- Peripheral arterial or venous disease
- History of compartment syndrome
- Limb anomalies
- General muscle disorder
- Participants under the influence of excessive alcohol, consumption of narcotics or benzodiazepines prior to procedure
- Participants under the effect of analgesic (\< 12 hours)
Key Trial Info
Start Date :
May 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 17 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05367921
Start Date
May 4 2022
End Date
May 17 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinik für Orthopädische Chirurgie und Traumatologie Inselspital
Bern, Switzerland, 3010